# Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS

> **NCT06839391** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Benha University** · enrollment: 120 (estimated)

## Conditions studied

- Tab Block Qaulity

## Interventions

- **DRUG:** Hyaluronidase

## Key facts

- **NCT ID:** NCT06839391
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839391, "Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06839391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*